Thrombosis |
From the Thrombosis and Haemostasis Laboratory (S.J.A.K., G.G., J.-W.N.A.), Department of Haematology, and Department of Clinical Chemistry (H.J.M.R.), University Medical Center Utrecht, and the Institute for Biomembranes (S.J.A.K., G.G., J.-W.N.A.), University of Utrecht, the Netherlands.
Correspondence to Dr J. W. N. Akkerman, Thrombosis and Haemostasis Laboratory, G.03.647, Department of Haematology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, the Netherlands. E-mail j.w.n.akkerman{at}azu.nl
Objective Because of the large variation in oxidizing procedures and susceptibility to oxidation of low-density lipoprotein (LDL) and the lack in quantification of LDL oxidation, the role of oxidation in LDLplatelet contact has remained elusive. This study aims to compare platelet activation by native LDL (nLDL) and oxidized LDL (oxLDL).
Methods and Results After isolation, nLDL was dialyzed against FeSO4 to obtain LDL oxidized to well-defined extents varying between 0% and >60%. The oxLDL preparations were characterized with respect to their platelet-activating properties. An increase in LDL oxidation enhances platelet activation via 2 independent pathways, 1 signaling via p38MAPK phosphorylation and 1 via Ca2+ mobilization. Between 0% and 15% oxidation, the p38MAPK route enhances fibrinogen binding induced by thrombin receptor (PAR-1)-activating peptide (TRAP), and signaling via Ca2+ is absent. At >30% oxidation, p38MAPK signaling increases further and is accompanied by Ca2+ mobilization and platelet aggregation in the absence of a second agonist. Despite the increase in p38MAPK signaling, synergism with TRAP disappears and oxLDL becomes an inhibitor of fibrinogen binding. Inhibition is accompanied by binding of oxLDL to the scavenger receptor CD36, which is associated with the fibrinogen receptor,
IIbß3.
Conclusion At >30% oxidation, LDL interferes with ligand binding to integrin
IIbß3, thereby attenuating platelet functions.
OxLDL modulates platelet function via distinct mechanisms. At <15% oxidation, agonist-induced platelet functions are enhanced through activation of a p38MAPK-mediated pathway. At >30% oxidation, oxLDL induces LPA-dependent Ca2+ mobilization, leading to immediate aggregation. At >15% oxidation, p38MAPK-induced sensitization disappears and oxLDL inhibits agonist-induced platelet functions by binding to CD36, thereby interfering with
IIbß3-mediated outside-in signaling.
Key Words: lipoproteins platelets oxidized LDL scavenger receptor lysophosphatidic acid
This article has been cited by other articles:
![]() |
E. Herczenik and M. F. B. G. Gebbink Molecular and cellular aspects of protein misfolding and disease FASEB J, July 1, 2008; 22(7): 2115 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, M. Febbraio, W. Li, and R. L. Silverstein A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein Circ. Res., June 20, 2008; 102(12): 1512 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Siegel-Axel, K. Daub, P. Seizer, S. Lindemann, and M. Gawaz Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis Cardiovasc Res, April 1, 2008; 78(1): 8 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI Blood, February 15, 2008; 111(4): 1962 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J.A. Korporaal, M. Van Eck, J. Adelmeijer, M. Ijsseldijk, R. Out, T. Lisman, P. J. Lenting, T. J.C. Van Berkel, and J.-W. N. Akkerman Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2476 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Herczenik, B. Bouma, S. J.A. Korporaal, R. Strangi, Q. Zeng, P. Gros, M. Van Eck, T. J.C. Van Berkel, M. F.B.G. Gebbink, and J.-W. N. Akkerman Activation of Human Platelets by Misfolded Proteins Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1657 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Daub, H. Langer, P. Seizer, K. Stellos, A. E. May, P. Goyal, B. Bigalke, T. Schonberger, T. Geisler, D. Siegel-Axel, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells FASEB J, December 1, 2006; 20(14): 2559 - 2561. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |